{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:31:32Z","timestamp":1757781092583,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019704","name":"Konkuk University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Given that patients with thyroid cancer experience several metabolic disorders, it is inferred that these patients have an elevated risk of non-alcoholic fatty liver disease (NAFLD). However, large-scale studies on this topic are lacking. This study aimed to elucidate the association between thyroid cancer and NAFLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We used data from the Korean National Health Insurance Service Sample Cohort. A total of 1,407 patients with thyroid cancer and 4,221 matched controls were included following the exclusion process and propensity score matching at a ratio of 1:3. We analyzed hazard ratio, risk factors for NAFLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study revealed an increased risk of NAFLD (HR 2.28; 95% CI 1.69\u20133.10; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) in patients with thyroid cancer. Thyroid cancer patients exhibited a higher risk of NAFLD when they had no regular exercise (HR 2.41; 95% CI 1.75\u20133.32). Moreover, body mass index (BMI) and levothyroxine dosage have been identified as potential critical factors for the development of NAFLD in patients with thyroid cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The incidence rate of NAFLD was higher in patients with thyroid cancer than in the controls. Healthcare professionals should consider regular physical activity, BMI, and cumulative levothyroxine dosage when managing patients with thyroid cancer to mitigate the incidence of NAFLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14485-2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:56:45Z","timestamp":1751353005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Young Bin","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9806-9839","authenticated-orcid":false,"given":"Kyoung Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"11","key":"14485_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1089\/thy.2016.0100","volume":"26","author":"JJ Wiltshire","year":"2016","unstructured":"Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP. Systematic review of trends in the incidence rates of thyroid Cancer. Thyroid. 2016;26(11):1541\u201352.","journal-title":"Thyroid"},{"issue":"2","key":"14485_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355\u201382.","journal-title":"Physiol Rev"},{"issue":"6","key":"14485_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3803\/EnM.2024.2251","volume":"39","author":"WG Kim","year":"2024","unstructured":"Kim WG. Trends in thyroid Cancer mortality rates in korea: insights from National health database. Endocrinol Metab. 2024;39(6):853\u20135.","journal-title":"Endocrinol Metab"},{"issue":"3","key":"14485_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u201352.","journal-title":"J Hepatol"},{"issue":"1","key":"14485_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","volume":"103","author":"I Pierantonelli","year":"2019","unstructured":"Pierantonelli I, Svegliati-Baroni G. Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation. 2019;103(1):e1\u201313.","journal-title":"Transplantation"},{"issue":"1","key":"14485_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"key":"14485_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1399517","volume":"15","author":"LL Xiang","year":"2024","unstructured":"Xiang LL, Cao YT, Sun J, Li RH, Qi F, Zhang YJ, et al. Association between thyroid function and nonalcoholic fatty liver disease: a dose-response meta-analysis. Front Endocrinol (Lausanne). 2024;15: 1399517.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"14485_CR8","doi-asserted-by":"publisher","first-page":"572128","DOI":"10.3389\/fendo.2020.572128","volume":"11","author":"M Borges-Canha","year":"2020","unstructured":"Borges-Canha M, Neves JS, Mendon\u00e7a F, Silva MM, Costa C, Cabral PM, et al. Thyroid function and the risk of Non-Alcoholic fatty liver disease in morbid obesity. Front Endocrinol (Lausanne). 2020;11:572128.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"14485_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/a-2276-7973","volume":"56","author":"Y Yang","year":"2024","unstructured":"Yang Y, Xiao J, Qiu W, Jiang L. Cross-talk between thyroid disorders and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Horm Metab Res. 2024;56(10):697\u2013705.","journal-title":"Horm Metab Res"},{"issue":"11","key":"14485_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.tem.2022.08.001","volume":"33","author":"E Hatziagelaki","year":"2022","unstructured":"Hatziagelaki E, Paschou SA, Sch\u00f6n M, Psaltopoulou T, Roden M. NAFLD and thyroid function: pathophysiological and therapeutic considerations. Trends Endocrinol Metab. 2022;33(11):755\u201368.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"14485_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12955-019-1181-2","volume":"17","author":"OF Ayilara","year":"2019","unstructured":"Ayilara OF, Zhang L, Sajobi TT, Sawatzky R, Bohm E, Lix LM. Impact of missing data on bias and precision when estimating change in patient-reported outcomes from a clinical registry. Health Qual Life Outcomes. 2019;17(1):106.","journal-title":"Health Qual Life Outcomes"},{"key":"14485_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12020-010-9339-z","volume":"37","author":"JL Reverter","year":"2010","unstructured":"Reverter JL, Colom\u00e9 E, Holgado S, Aguilera E, Soldevila B, Mateo L, et al. Bone mineral density and bone fracture in male patients receiving long-term suppressive Levothyroxine treatment for differentiated thyroid carcinoma. Endocrine. 2010;37:467\u201372.","journal-title":"Endocrine"},{"issue":"1","key":"14485_CR13","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1210\/clinem\/dgad418","volume":"109","author":"S Korpim\u00e4ki","year":"2024","unstructured":"Korpim\u00e4ki S, Rovio SP, Juonala M, Hutri-K\u00e4h\u00f6nen N, Lehtim\u00e4ki T, Laitinen TP, et al. Nonalcoholic fatty liver disease incidence and remission and their predictors during 7 years of Follow-up among Finns. J Clin Endocrinol Metab. 2024;109(1):e291\u2013305.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"14485_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/jgh.15236","volume":"36","author":"JH Pyo","year":"2021","unstructured":"Pyo JH, Kim TJ, Lee H, Choi SC, Cho SJ, Choi YH, et al. Proton pump inhibitors use and the risk of fatty liver disease: a nationwide cohort study. J Gastroenterol Hepatol. 2021;36(5):1235\u201343.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"14485_CR15","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.1210\/clinem\/dgab776","volume":"107","author":"E Roh","year":"2022","unstructured":"Roh E, Noh E, Hwang SY, Kim JA, Song E, Park M, et al. Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: a nationwide cohort study. J Clin Endocrinol Metab. 2022;107(3):e1047\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"14485_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2174\/1871530321666201216164410","volume":"21","author":"NV Mohamad","year":"2021","unstructured":"Mohamad NV, Ima-Nirwana S, Chin KY. The skeletal effects of gonadotropin-releasing hormone antagonists: a concise review. Endocr Metab Immune Disord Drug Targets. 2021;21(10):1713\u201320.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"14485_CR17","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1210\/clinem\/dgad575","volume":"109","author":"H Kwon","year":"2024","unstructured":"Kwon H, Han KD, Moon SJ, Park SE, Rhee EJ, Lee WY. Nonalcoholic fatty liver disease and the risk of thyroid cancer among young adults in South Korea. J Clin Endocrinol Metab. 2024;109(3):e1095\u2013104.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"14485_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.trsl.2007.12.006","volume":"151","author":"F Teixeira Pde","year":"2008","unstructured":"Teixeira Pde F, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Buescu A, et al. Lipid profile in different degrees of hypothyroidism and effects of Levothyroxine replacement in mild thyroid failure. Transl Res. 2008;151(4):224\u201331.","journal-title":"Transl Res"},{"key":"14485_CR19","doi-asserted-by":"publisher","first-page":"15273","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan R, Wang J, Du J. Association between body mass index and fatty liver risk: A dose-response analysis. Sci Rep. 2018;8:15273.","journal-title":"Sci Rep"},{"issue":"8","key":"14485_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/thy.2009.0212","volume":"20","author":"S Gjedde","year":"2010","unstructured":"Gjedde S, Gormsen LC, Rungby J, Nielsen S, J\u00f8rgensen JO, Pedersen SB, et al. Decreased lipid intermediate levels and lipid oxidation rates despite normal lipolysis in patients with hypothyroidism. Thyroid. 2010;20(8):843\u20139.","journal-title":"Thyroid"},{"key":"14485_CR21","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1210\/jc.2003-031669","volume":"89","author":"F Monzani","year":"2004","unstructured":"Monzani F, Caraccio N, Koz\u00e0kow\u00e0 M, Dardano A, Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004;89:2099\u2013106.","journal-title":"J Clin Endocrinol Metab"},{"key":"14485_CR22","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","volume":"87","author":"N Caraccio","year":"2002","unstructured":"Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to Levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87:1533\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"14485_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12967-023-04047-0","volume":"21","author":"S Lu","year":"2023","unstructured":"Lu S, Xie Q, Kuang M, Chong H, Xinghui L, Huijian Y, et al. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Transl Med. 2023;21(1):192.","journal-title":"J Transl Med"},{"issue":"6","key":"14485_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510\u20139.","journal-title":"Obes Rev"},{"issue":"1","key":"14485_CR25","doi-asserted-by":"publisher","first-page":"23784","DOI":"10.1038\/s41598-024-72013-x","volume":"14","author":"EM Elkenawy","year":"2024","unstructured":"Elkenawy EM, Alhussan AA, Khafaga DS, Tarek Z, Elshewey AM. Greylag goose optimization and multilayer perceptron for enhancing lung cancer classification. Sci Rep. 2024;14(1):23784.","journal-title":"Sci Rep"},{"issue":"6","key":"14485_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/biomimetics8060457","volume":"8","author":"EH Alkhammash","year":"2023","unstructured":"Alkhammash EH, Assiri SA, Nemenqani DM, Althaqafi RMM, Hadjouni M, Saeed F, et al. Application of machine learning to predict COVID-19 spread via an optimized BPSO model. Biomimetics. 2023;8(6):457.","journal-title":"Biomimetics"},{"key":"14485_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2024.107417","volume":"102","author":"Z Tarek","year":"2025","unstructured":"Tarek Z, Alhussan AA, Khafaga DS, El-Kenawy ESM, Elshewey AM. A snake optimization algorithm-based feature selection framework for rapid detection of cardiovascular disease in its early stages. Biomed Signal Process Control. 2025;102: 107417.","journal-title":"Biomed Signal Process Control"},{"key":"14485_CR28","doi-asserted-by":"publisher","first-page":"24489","DOI":"10.1038\/s41598-024-74475-5","volume":"14","author":"M Elshewey","year":"2024","unstructured":"Elshewey M, Alhussan AA, Khafaga DS, Elkenawy ESM, Tarek Z. EEG-based optimization of eye state classification using modified-BER metaheuristic algorithm. Sci Rep. 2024;14:24489.","journal-title":"Sci Rep"},{"key":"14485_CR29","first-page":"695","volume":"68","author":"SA Alzakari","year":"2024","unstructured":"Alzakari SA, Alhussan AA, Qenawy AST, Elshewey AM. Early detection of potato disease using an enhanced convolutional neural network-long short-term memory deep learning model. Potato Res. 2024;68:695\u2013713.","journal-title":"Potato Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14485-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:03:44Z","timestamp":1751396624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14485-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14485"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14485-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Konkuk University Medical Center (KUMC 2024-08-018). We conducted this study in strict adherence to Helsinki Declaration. Owing to the anonymization of the National Health Insurance Service data and the stringent control of researchers\u2019 access, the requirement for informed consent was waived by the National Health Insurance Service.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1093"}}